Parliament Workbench
Data: Motions & questions to 26 Nov 2026

Written Question · S3W-23621 · Session 3

What the Scottish Medicines Consortium has done to develop its work on estimating the anticipated budget impact of new medicines.

Answered Asked by George Foulkes Lab Lodged 6 May 2009

The question

To ask the Scottish Executive what the Scottish Medicines Consortium has done to develop its work on estimating the anticipated budget impact of new medicines.

The answer

Answered by Nicola Sturgeon on 13 May 2009 · 7 days after it was lodged, on time

Budget impact information is provided to NHS boards by the Scottish Medicines Consortium (SMC) for all new medicines assessed. These estimates are intended to give NHS boards an indication of the financial implications if the product is accepted for use within NHSScotland. The SMC also carries out horizon scanning to provide early intelligence on new medicines and support local financial planning.
Following a recent SMC Evaluation, the SMC is working with the pharmaceutical industry through a Short Life Working Group to review the relevant processes to enable consistency in the standard and presentation of budget impact information. The group expects to report to the SMC in the autumn 2009.

In the Official Report

No contribution in the Official Report cites S3W-23621 by reference.